Research Library

The 10th in a series of reports on the implementation of the ACA analyzes the costs and coverage of marketplace plans in Texas.

In the current campaign for Harris County district attorney, both incumbent D.A. Devon Anderson and challenger Kim Ogg have not only proposed to change the way marijuana use is handled by that office, but have also made the issue a centerpiece of their campaigns. Drug policy fellow Katharine Neill examines each candidate’s proposed changes in a new Baker Institute Blog.

The human papillomavirus (HPV) affects over 80 million Americans, causing more than 40,000 cases of HPV-associated cancers in the U.S. In 2006, the FDA licensed the first HPV vaccine, which could help save thousands of lives; no cure for HPV currently exists. However, the political controversy raised by the vaccine has limited its acceptance and use. Such resistance potentially jeopardizes an opportunity to reduce cancer rates in Texas and the broader United States.

Stem cells from umbilical cord blood (CB) can be used to treat over 80 different diseases, including many types of leukemia, lymphoma and inherited immune system disorders. Extensive storage facilities in the United States and around the world collect, test and freeze CB for later use in medical procedures. However, the divide between two different banking models — public versus private — presents policy challenges. This policy report examines the difference between public and private cord blood banks and offers recommendations for US policymakers to improve cord blood banking and ensure high quality standards.

This study aimed to develop a systematic approach to classifying childhood cancer-related admissions in administrative data into categories that reflected clinical practice and predicted resource use.

Marijuana decriminalization and legalization have gone past being a trend and are settling in as federal policy, writes nonresident fellow Gary Hale, a 31-year veteran of the Drug Enforcement Administration. This policy brief includes recommendations for how the DEA can adjust its policies to adopt a new paradigm on marijuana policy.

Public finance fellow John Diamond analyzed the proposed Tax Reform Act of 2014 in testimony before the House Subcommittee on Select Revenue Measures on July 30, 2014.